Skip to main content

Table 1 Participant characteristics at baseline and three-month follow-up interview (N = 255)

From: Is use of opioid agonist treatment associated with broader primary healthcare use among men with recent injecting drug use histories following release from prison? A prospective cohort study

 

n (%a)

Baseline

 

  Age (mean, [SDb])

36 (8)

  Aboriginal and/or Torres Strait Islander

40 (16)

  Chronic health condition

170 (67)

  Mental health condition

213 (84)

Follow-up

 

  Area of residence

 

    Metropolitan

129 (51)

    Regional

84 (33)

    Prison

42 (16)

  Times moved accommodation

 

    0

110 (43)

    1–2

75 (29)

    3 + 

70 (27)

  Current accommodation unstable

40 (16)

  Main drug injected in past 30 days

 

    Heroin

32 (13)

    Methamphetamine

72 (28)

    Methamphetamine and heroin

53 (21)

    Neither methamphetamine or heroin

98 (38)

  GHQ-12 score (median, [IQRc])

3 (1–6)

  Self-reported fair or poor health

75 (29)

  Current support worker

72 (28)

  OAT exposure

 

    None

148 (58)

    Partial

32 (13)

    Complete

75 (29)

  1. aPercentages may not add to 100% due to rounding; bStandard deviation; cInterquartile range